Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided.
Type:
Grant
Filed:
September 5, 2001
Date of Patent:
May 9, 2006
Assignee:
Phylonix Pharmaceuticals, Inc.
Inventors:
George N. Serbedzija, Carlos Semino, Deanna Frost
Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
Type:
Application
Filed:
April 25, 2005
Publication date:
August 25, 2005
Applicant:
Phylonix Pharmaceuticals, Inc.
Inventors:
George Serbedzija, Carlos Semino, Deanna Frost
Abstract: The invention provides methods of introducing heterologous cells into fish. After introduction cells remain viable, and in some instances proliferate, for sufficient time to conduct a variety of analyses on the heterologous cells or the fish or both. Such methods are useful for screening potential drugs for toxicity toward introduced cells or for capacity to stimulate differentiation and/or proliferation of introduced cells. Such methods are also useful for diagnosing the presence of small quantities of cancerous cells or pathogens in patient tissue samples. Such methods are also useful for culturing cells for subsequent use in cell or tissue engineering.
Abstract: The invention provides methods of introducing heterologous cells into fish. After introduction cells remain viable, and in some instances proliferate, for sufficient time to conduct a variety of analyses on the heterologous cells or the fish or both. Such methods are useful for screening potential drugs for toxicity toward introduced cells or for capacity to stimulate differentiation and/or proliferation of introduced cells. Such methods are also useful for diagnosing the presence of small quantities of cancerous cells or pathogens in patient tissue samples. Such methods are also useful for culturing cells for subsequent use in cell or tissue engineering.
Type:
Grant
Filed:
November 30, 1999
Date of Patent:
July 13, 2004
Assignee:
Phylonix Pharmaceuticals, Inc.
Inventors:
George N. Serbedzija, Carlos E. Semino, Patricia McGrath
Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
Type:
Application
Filed:
October 2, 2003
Publication date:
April 1, 2004
Applicant:
Phylonix Pharmaceuticals, Inc.
Inventors:
George N, Serbedzija, Carlos Semino, Deanna M. Frost
Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
Type:
Grant
Filed:
August 23, 2000
Date of Patent:
December 2, 2003
Assignee:
Phylonix Pharmaceuticals, Inc.
Inventors:
George Serbedzija, Wen Lin Seng, Patricia McGrath
Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided.
Type:
Grant
Filed:
February 22, 1999
Date of Patent:
October 9, 2001
Assignee:
Phylonix Pharmaceuticals, Inc.
Inventors:
George N. Serbedzija, Carlos Semino, Deanna Frost